The burgeoning field ofinvestigations into novel anxiolytics is rapidly expanding, with novel research chemicals showing encouraging results in preclinical and clinical trials. These molecules often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential advantages for individuals struggling with a